243 related articles for article (PubMed ID: 23384772)
1. Therapeutic potential of neuregulin-1 in cardiovascular disease.
Mendes-Ferreira P; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
Drug Discov Today; 2013 Sep; 18(17-18):836-42. PubMed ID: 23384772
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin-1/ErbB signaling and chronic heart failure.
Xu Y; Li X; Liu X; Zhou M
Adv Pharmacol; 2010; 59():31-51. PubMed ID: 20933198
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Potential of Neuregulin in Cardiovascular System: Can we Ignore the Effects of Neuregulin on Electrophysiology?
Wang X; Liu Z; Duan HN; Wang L
Mini Rev Med Chem; 2016; 16(11):867-71. PubMed ID: 26902151
[TBL] [Abstract][Full Text] [Related]
4. Neuregulin as a heart failure therapy and mediator of reverse remodeling.
Galindo CL; Ryzhov S; Sawyer DB
Curr Heart Fail Rep; 2014 Mar; 11(1):40-9. PubMed ID: 24234399
[TBL] [Abstract][Full Text] [Related]
5. Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure.
Lemmens K; Doggen K; De Keulenaer GW
Circulation; 2007 Aug; 116(8):954-60. PubMed ID: 17709650
[TBL] [Abstract][Full Text] [Related]
6. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin-1/ErbB signaling: a druggable target for treating heart failure.
Xu Y; Li X; Zhou M
Curr Opin Pharmacol; 2009 Apr; 9(2):214-9. PubMed ID: 19070544
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
Frohnert PW; Stonecypher MS; Carroll SL
Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of sphingosine-1-phosphate (S1P).
Levkau B
Handb Exp Pharmacol; 2013; (216):147-70. PubMed ID: 23563656
[TBL] [Abstract][Full Text] [Related]
10. Relaxin' the Heart: A Novel Therapeutic Modality.
Raleigh JM; Toldo S; Das A; Abbate A; Salloum FN
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):353-62. PubMed ID: 26589290
[TBL] [Abstract][Full Text] [Related]
11. Neuregulin1 as novel therapy for heart failure.
Yan X; Morgan JP
Curr Pharm Des; 2011; 17(18):1808-17. PubMed ID: 21631420
[TBL] [Abstract][Full Text] [Related]
12. Urocortin 2 in cardiovascular health and disease.
Adão R; Santos-Ribeiro D; Rademaker MT; Leite-Moreira AF; Brás-Silva C
Drug Discov Today; 2015 Jul; 20(7):906-14. PubMed ID: 25748088
[TBL] [Abstract][Full Text] [Related]
13. The vulnerability of the heart as a pluricellular paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer therapy.
De Keulenaer GW; Doggen K; Lemmens K
Circ Res; 2010 Jan; 106(1):35-46. PubMed ID: 20056944
[TBL] [Abstract][Full Text] [Related]
14. Cytostatic drugs, neuregulin activation of erbB receptors, and angiogenesis.
Hedhli N; Russell KS
Curr Hypertens Rep; 2010 Dec; 12(6):411-7. PubMed ID: 20878505
[TBL] [Abstract][Full Text] [Related]
15. Neuregulin-1 signaling in the pathogenesis of chemotherapy-induced heart failure.
Lenneman CG
Curr Heart Fail Rep; 2014 Jun; 11(2):134-8. PubMed ID: 24682830
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of neuregulin-1/ErbB signaling: role in vascular signaling and angiogenesis.
Hedhli N; Kalinowski A; S Russell K
Curr Pharm Des; 2014; 20(30):4899-905. PubMed ID: 24283954
[TBL] [Abstract][Full Text] [Related]
17. Localization of neuregulin isoforms and erbB receptors in myelinating glial cells.
Raabe TD; Deadwyler G; Varga JW; Devries GH
Glia; 2004 Jan; 45(2):197-207. PubMed ID: 14730713
[TBL] [Abstract][Full Text] [Related]
18. Transactivation of ErbB receptors by leptin in the cardiovascular system: mechanisms, consequences and target for therapy.
Bełtowski J; Jazmroz-Wiśniewska A
Curr Pharm Des; 2014; 20(4):616-24. PubMed ID: 23688012
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin-induced expression of the acetylcholine receptor requires endocytosis of ErbB receptors.
Yang XL; Huang YZ; Xiong WC; Mei L
Mol Cell Neurosci; 2005 Feb; 28(2):335-46. PubMed ID: 15691714
[TBL] [Abstract][Full Text] [Related]
20. The Future of Cardiovascular Therapeutics.
MacRae CA; Roden DM; Loscalzo J
Circulation; 2016 Jun; 133(25):2610-7. PubMed ID: 27324356
[No Abstract] [Full Text] [Related]
[Next] [New Search]
